The state of the art on acetylcholinesterase inhibitors in the treatment of Alzheimer’s disease I Vecchio, L Sorrentino, A Paoletti, R Marra, M Arbitrio Journal of Central nervous system disease 13, 11795735211029113, 2021 | 120 | 2021 |
Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts MR Pitari, M Rossi, N Amodio, C Botta, E Morelli, C Federico, A Gullą, ... Oncotarget 6 (29), 27343, 2015 | 115 | 2015 |
Nanoparticle albumin bound paclitaxel in the treatment of human cancer: nanodelivery reaches prime‐time? I Cucinotto, L Fiorillo, S Gualtieri, M Arbitrio, D Ciliberto, N Staropoli, ... Journal of Drug Delivery 2013 (1), 905091, 2013 | 107 | 2013 |
Single nucleotide polymorphisms of ABCC5 and ABCG1 transporter genes correlate to irinotecan-associated gastrointestinal toxicity in colorectal cancer patients: a DMET … MT Di Martino, M Arbitrio, E Leone, PH Guzzi, M Saveria Rotundo, ... Cancer biology & therapy 12 (9), 780-787, 2011 | 107 | 2011 |
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review MT Di Martino, M Arbitrio, D Caracciolo, A Cordua, O Cuomo, K Grillone, ... Molecular Therapy-Nucleic Acids 27, 1191-1224, 2022 | 90 | 2022 |
DMET™(Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine M Arbitrio, MT Di Martino, F Scionti, G Agapito, PH Guzzi, M Cannataro, ... Oncotarget 7 (33), 54028, 2016 | 83 | 2016 |
In vivo anti‐myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitor P Neri, P Tagliaferri, MT Di Martino, T Calimeri, N Amodio, A Bulotta, ... British journal of haematology 143 (4), 520-531, 2008 | 83 | 2008 |
DMET-analyzer: automatic analysis of Affymetrix DMET data PH Guzzi, G Agapito, MT Di Martino, M Arbitrio, P Tassone, P Tagliaferri, ... BMC bioinformatics 13, 1-10, 2012 | 81 | 2012 |
A peroxisome proliferator-activated receptor gamma (PPARG) polymorphism is associated with zoledronic acid-related osteonecrosis of the jaw in multiple myeloma patients … MT Di Martino, M Arbitrio, PH Guzzi, E Leone, F Baudi, E Piro, T Prantera, ... British journal of haematology 154 (4), 529, 2011 | 77 | 2011 |
Identification of polymorphic variants associated with erlotinib-related skin toxicity in advanced non-small cell lung cancer patients by DMET microarray analysis M Arbitrio, MT Di Martino, V Barbieri, G Agapito, PH Guzzi, C Botta, ... Cancer chemotherapy and pharmacology 77, 205-209, 2016 | 76 | 2016 |
Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma MA Stamato, G Juli, E Romeo, D Ronchetti, M Arbitrio, D Caracciolo, ... Oncotarget 8 (63), 106527, 2017 | 71 | 2017 |
miRNAs and lncRNAs as novel therapeutic targets to improve cancer immunotherapy MT Di Martino, C Riillo, F Scionti, K Grillone, N Polerą, D Caracciolo, ... Cancers 13 (7), 1587, 2021 | 70 | 2021 |
Pharmacogenomics biomarker discovery and validation for translation in clinical practice M Arbitrio, F Scionti, MT Di Martino, D Caracciolo, L Pensabene, ... Clinical and Translational Science 14 (1), 113-119, 2021 | 70 | 2021 |
From single level analysis to multi-omics integrative approaches: a powerful strategy towards the precision oncology MEG Cantafio, K Grillone, D Caracciolo, F Scionti, M Arbitrio, V Barbieri, ... The Road from Nanomedicine to Precision Medicine, 829-869, 2019 | 67 | 2019 |
Pharmacokinetics and Pharmacodynamics of a 13-mer LNA-inhibitor-miR-221 in Mice and Non-human Primates MEG Cantafio, BS Nielsen, C Mignogna, M Arbitrio, C Botta, NM Frandsen, ... Molecular Therapy-Nucleic Acids 5, 2016 | 60 | 2016 |
miR-22 suppresses DNA ligase III addiction in multiple myeloma D Caracciolo, MT Di Martino, N Amodio, E Morelli, M Montesano, C Botta, ... Leukemia 33 (2), 487-498, 2019 | 55 | 2019 |
Mouse models of multiple myeloma: technologic platforms and perspectives M Rossi, C Botta, M Arbitrio, RD Grembiale, P Tagliaferri, P Tassone Oncotarget 9 (28), 20119, 2018 | 55 | 2018 |
miR-21 antagonism abrogates Th17 tumor promoting functions in multiple myeloma M Rossi, E Altomare, C Botta, ME Gallo Cantafio, S Sarvide, D Caracciolo, ... Leukemia 35 (3), 823-834, 2021 | 48 | 2021 |
Evidence for an involvement of dopamine D1 receptors in the limbic system in the control of immune mechanisms G Nisticó, MC Caroleo, M Arbitrio, L Pulvirenti Neuroimmunomodulation 1 (3), 174-180, 1994 | 48 | 1994 |
Hematopoietic reconstitution after lethal irradiation and bone marrow transplantation: effects of different hematopoietic cytokines on the recovery of thymus, spleen and blood … D Frasca, F Guidi, M Arbitrio, C Pioli, F Poccia, R Cicconi, G Doria Bone marrow transplantation 25 (4), 427-433, 2000 | 45 | 2000 |